HT-1376 In Vitro WST Assay (Cell Viability)

CAT#: ITS-1022-YF2840
Target Cell Organism: Human
Target Cell Name: HT-1376
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide HT-1376-based In Vitro WST Assay (Cell Viability) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HT-1376
Target Cell Organism
Human
Target Cell Background
HT-1376 is an epithelial-like cell isolated from the urinary bladder of a White, 58-year-old, female with carcinoma. This cell line was deposited by S Rasheed and can be used for immuno-oncology research.
Related Diseases
Urinary Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro WST Assay (Cell Viability)
Short Description
HT-1376-cell based In Vitro WST Assay (Cell Viability)
Assay Description
Apart from the MTT tetrazolium, other tetrazolium compounds such as WST (reagent series) can also generate formazan upon reduction by oxidoreductase or dehydrogenase. Unlike the normal MTT assay, assays with these regents (MTS, XTT and WST) do not require formazan solubilization step as solubilization occurs in the cell medium itself. Therefore, XTT, WST and MTS reagents can be used to assay viability of cells, which do not require a surface to attach.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Viability Assay
Assay MOA
Cell-based Viability Assays Based on Cellular Enzymes and Proteins
For Research Use Only | Not For Clinical Use
Online Inquiry